Novartis suffers another setback for Prexige debut
Article Abstract:
Novartis AG is postponing the launch of its Prexige painkilling drug after the US Food and Drug Administration requested additional data. The FDA wants more data on the drug's effectiveness and safety.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Novartis AG
Article Abstract:
The US Food and Drug Administration has told Novartis AG that information had to be added to its Zometa drug's label before its approval can be expanded. Zometa is designed to treat cancer.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Novartis AG
Article Abstract:
Novartis AG's Prexige painkiller drug has been approved in the United Kingdom. The approval shows that Novartis may launch the drug worldwide in 2004.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Novartis drug approved by EU. Novartis has potential blockbuster as FDA backs blood-pressure drug
- Abstracts: Profits grow from feeding the world. China: red alert
- Abstracts: Loose wire: the pen is mightier than the computer, too. Beware E-voting. Behind the myth: Macs are not miraculous, they're really just better PCs
- Abstracts: NatWest names Rowland to succeed Lord Alexander as chairman in April
- Abstracts: France studies steps to fix Airbus problems. France's Total bids $1.12 billion for Canadian firm Deer Creek. Air France, KLM plan linkup